| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/11/2011 | US20110195858 Systems and methods of analyzing biomarker levels |
| 08/11/2011 | US20110195854 Detecting and monitoring inflammatory neuropathy |
| 08/11/2011 | US20110195849 METHODS AND COMPOSITIONS FOR IDENTIFYING INHIBITORS OF MUTS-alpha OR MUTS-beta INTERACTION WITH MUTL-alpha |
| 08/11/2011 | US20110195848 Gene expression and breast cancer |
| 08/11/2011 | US20110195479 Polymerase |
| 08/11/2011 | US20110195447 Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-ALPHA |
| 08/11/2011 | US20110195446 Method and kit for semen diagnosis through color changes in methylene blue and semen quality evaluation using same |
| 08/11/2011 | US20110195445 Methods and systems for fluid examination and remediation |
| 08/11/2011 | US20110195444 Novel protein having fructosyl valyl histidine oxidase activity, modified protein, and use of the protein or the modified protein |
| 08/11/2011 | US20110195443 Screening Method for Identifying Protease Secretion-Deficient Mutants of Microorganisms |
| 08/11/2011 | US20110195442 Sterility indicating biological compositions, articles and methods |
| 08/11/2011 | US20110195441 method and assembly for measuring thrombin generation in plasma |
| 08/11/2011 | US20110195440 Systems and methods for identifying allergies |
| 08/11/2011 | US20110195439 Systems and methods for determining cardiac conditions |
| 08/11/2011 | US20110195437 Method for characterizing, in particular for quantifying, molecular markers that are intracellularly absorbed from tissues by blood macrophages that are recirculated from the tissues into the circulatory system |
| 08/11/2011 | US20110195432 Methods for the selection of therapeutic treatments for cancer |
| 08/11/2011 | US20110195431 Human orphan g protein-coupled receptors |
| 08/11/2011 | US20110195427 Systems and methods for detecting pregnancy |
| 08/11/2011 | US20110195426 Nucleic acids analysis |
| 08/11/2011 | US20110195425 Systems and methods for diagnosing parasite infections |
| 08/11/2011 | US20110195424 Systems and methods for diagnosing fungal infections |
| 08/11/2011 | US20110195423 Systems and methods for diagnosing bacterial infections |
| 08/11/2011 | US20110195422 Methods for determining the efficiency of a therapeutic |
| 08/11/2011 | US20110195421 Methods of identifying biomarkers for cancer |
| 08/11/2011 | US20110195420 Estrogen and anti-estrogen marker genes |
| 08/11/2011 | US20110195419 Therapeutic use of farnesyltransferase inhibitors and methods of monitoring the efficacy thereof |
| 08/11/2011 | US20110195418 Method of simultaneous detection of viroids |
| 08/11/2011 | US20110195417 Device for Thermally Regulating a Rotationally Symmetrical Container |
| 08/11/2011 | US20110195416 Disease detection by digital protein truncation assays |
| 08/11/2011 | US20110195415 Guanylyl cyclase c qrt-pcr |
| 08/11/2011 | US20110195414 Method and Markers for Determining the Genotype of Horned/Polled Cattle |
| 08/11/2011 | US20110195413 Integrated Method for Enriching and Detecting Rare Cells from Biological Body Fluid Sample |
| 08/11/2011 | US20110195412 Predictive Biomarkers for Response to Exercise |
| 08/11/2011 | US20110195411 Arl-1 specific antibodies and uses thereof |
| 08/11/2011 | US20110195410 Compositions and methods related to solid phase sequence detection and genotyping |
| 08/11/2011 | US20110195409 Streptococcus pyogenes classification |
| 08/11/2011 | US20110195408 Labeling Dye for Detecting Biomolecule, Labeling Kit, and Method for Detecting Biomolecule |
| 08/11/2011 | US20110195407 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and uses of the same |
| 08/11/2011 | US20110195406 Intermittent detection during analytical reactions |
| 08/11/2011 | US20110195405 Compositions, methods, and kits for analyzing dna methylation |
| 08/11/2011 | US20110195404 Systems and methods for determining calcium levels |
| 08/11/2011 | US20110195403 Systems and methods for fertility analysis |
| 08/11/2011 | US20110195402 Systems and methods for detecting drug use |
| 08/11/2011 | US20110195401 Systems and methods for determining food allergies |
| 08/11/2011 | US20110195400 Systems and methods for diagnosing cancer |
| 08/11/2011 | US20110195399 Systems and methods for the inhibition of galactose oxidase |
| 08/11/2011 | US20110195398 Systems and methods for detecting insulin resistance biomarkers |
| 08/11/2011 | US20110195397 Drink mixture for the stabilization of diagnostic biomarkers |
| 08/11/2011 | US20110195396 Chewable compositions for the stabilization of diagnostic biomarkers |
| 08/11/2011 | US20110195395 Rinse composition for the stabilization of diagnostic biomarkers |
| 08/11/2011 | US20110195394 Systems and methods for diagnosing viral infections |
| 08/11/2011 | US20110195133 Dermcidin-derived peptides for lung cancer diagnostics |
| 08/11/2011 | US20110195078 Tat-based immunomodulatory compositions and methods for their discovery and use |
| 08/11/2011 | US20110195074 Ephrin Type-A Receptor 7 Protein |
| 08/11/2011 | US20110195072 Non-neuroendocrine cancer therapy |
| 08/11/2011 | US20110195070 Detection of granulosa-cell tumors |
| 08/11/2011 | US20110195056 Compositions comprising hepatocyte-like cells and uses thereof |
| 08/11/2011 | US20110195055 Method and apparatus for holding cells |
| 08/11/2011 | US20110195050 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 08/11/2011 | US20110195045 Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors |
| 08/11/2011 | US20110195025 Anionic oligosaccharide conjugates |
| 08/11/2011 | US20110192778 Integrated high throughput system for the analysis of biomolecules |
| 08/11/2011 | DE102010007548A1 Microarray consisting of spots, at which mixture of polymerase and sequence specific primers is immobilized and coated with substrate, in which enzyme enabling sequence specific amplification is added, useful to genotype and quantify DNA |
| 08/11/2011 | DE102010007243A1 Therapieoptimierung bei Krebspatienten durch Austesten von Therapiekombinationen mittels in vitro Testungen (Zusatz) Optimizing therapy for cancer patients by testing combinations of therapy by in vitro tests (additional) |
| 08/11/2011 | DE10121283B4 Verfahren und Vektoren zur Amplifikation oder Expression von gewünschten Nucleinsäuresequenzen in Pflanzen Methods and vectors for amplification or expression of the desired nucleic acid sequences in plants |
| 08/11/2011 | CA2794473A1 Induced hepatic stem cell and process for production thereof, and applications of the cell |
| 08/11/2011 | CA2791309A1 Hypoxia-related gene signatures for cancer classification |
| 08/11/2011 | CA2789168A1 Methods and compositions for predicting responsiveness to treatment with tnf-.alpha. inhibitor |
| 08/11/2011 | CA2789147A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 08/11/2011 | CA2789038A1 Selective reduction of allelic variants |
| 08/11/2011 | CA2788826A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 08/11/2011 | CA2788583A1 Complexity reduction method |
| 08/11/2011 | CA2788579A1 Methods of isolating and culturing mesenchymal stem cells |
| 08/11/2011 | CA2788331A1 Systems and methods for manipulating a molecule in nanopore |
| 08/11/2011 | CA2786974A1 Identification, assessment, and therapy of cancers with innate or acquired resistance to alk inhibitors |
| 08/11/2011 | CA2773101A1 Controlled tunnel gap device for sequencing polymers |
| 08/10/2011 | EP2354987A2 Method for predicting activation energy using an atomic fingerprint descriptor or an atomic descriptor |
| 08/10/2011 | EP2354793A2 Nucleic acids and proteins of insect OR83B odorant receptor genes and uses thereof |
| 08/10/2011 | EP2354791A1 Immunocytokines with modulated selectivity |
| 08/10/2011 | EP2354256A1 Thermal cycling device |
| 08/10/2011 | EP2354255A1 Methods for optimizing clinical responsiveness to methrotrexate therapy using metabolite profiling |
| 08/10/2011 | EP2354254A1 Biomarkers for assessing response to C-met treatment |
| 08/10/2011 | EP2354253A2 Method for non-invasive prenatal diagnosis |
| 08/10/2011 | EP2354252A1 Invasive cleavage of nucleic acids |
| 08/10/2011 | EP2354251A1 Compositons and methods for reverse transcriptase-Polymerase chain reaction (RT-PCR) |
| 08/10/2011 | EP2354250A1 Methods and nucleic acids for analyses of colorectal cell proliferative disorders |
| 08/10/2011 | EP2354249A1 Methods and nucleic acids for analyses of colorectal cell proliferative disorders |
| 08/10/2011 | EP2354248A1 Methods and nucleic acids for analyses of colorectal cell proliferative disorders |
| 08/10/2011 | EP2354247A1 Means and methods for typing a sample for rheumatoid arthritis or spondyloarthritis |
| 08/10/2011 | EP2354246A1 miRNA in the diagnosis of ovarian cancer |
| 08/10/2011 | EP2354245A1 MBL2 as a marker of hepatic PPAR- activity |
| 08/10/2011 | EP2354244A1 MBL2 as a marker of liver-specific insulin resistance |
| 08/10/2011 | EP2354243A1 Complexity reduction method |
| 08/10/2011 | EP2354242A1 Assay for determining the type and/or status of a cell based on the epigenetic pattern and the chromatin structure |
| 08/10/2011 | EP2354241A1 Mechanism and method of preventing suction air from leaking during filtration of a capturing carrier solution |
| 08/10/2011 | EP2354230A1 Neisseria meningitidis surface protein |
| 08/10/2011 | EP2354228A2 Identification marker responsive to interferon therapy for renal cell cancer |
| 08/10/2011 | EP2354227A1 Genes with ES cell-specific expression |
| 08/10/2011 | EP2354226A1 Method for detecting controls for nucleic acid amplification, and use thereof |
| 08/10/2011 | EP2354225A1 Aptamer for ngf and use thereof |